Ramírez MJJ, Soria LJA, Ambriz LR, Iglesias BJL

Language: Spanish
References: 10
Page: 195-200
PDF size: 215.84 Kb.

ABSTRACT

Background: Rupture premature of membranes occurs in 8 % of all births constituting one of main causes of prematurity.
Objective: Determine qualitatively the presence of human chorionic gonadotropin hormone in vagina and used as diagnostic test to rupture of membranes.
Patients and Method: We performed a study of diagnostic test observational, transverse, comparative, prospective, not blind type; in 175 healthy pregnant woman with 20 to 42 weeks of gestation, with suspicion of vaginal liquid outlet, at the Obstetrics Department Academic Hospital “Dr. Jose Eleuterio Gonzalez” during the period of April 2009 to June 2011, crystallography and vaginal human chorionic gonadotropin hormone test were performed.
Results: We analyzed 175 patients, average age was 22.35 years old, was obtained sensibility and specificity of 98.90% y 77.38% to crystallography and 93.41% y 73.81% to vaginal human chorionic gonadotropin hormone test, with value positive predictive of 79.44% and value negative predictive of 91.18% for this last.
Conclusions: Determine qualitatively the presence of human chorionic gonadotropin hormone in vagina is a diagnostic test useful for detecting premature rupture of membranes has been shown to be as effective as crystallography.

REFERENCES

1. Clinical management guidelines for obstetrician gynecologist. ACOG Practice Bulletin 2007;109:1007-1019.

2. Mercer BM. Preterm premature rupture of the membranes. ACOG 2003;101:178-193.

3. Méndez González JA, Aguirre Ramos G, Álvarez Valero R, Velázquez Magaña M, Rojas Poceros G. Hormona gonadotropina coriónica humana vaginal versus cristalografía y papel de nitrazina para el diagnóstico de rotura prematura de membranas. Anal Méd Mex 2007;52(1):22-26.

4. Guevara Zambrano AM, Vergara Pérez MI, Gutiérrez Marín JH, Sanín Blair JE. Amnioinfusión con índigo carmín en sospecha de rotura prematura de membranas ovulares pretérmino. Rev Col Obst Gin 2007;58(3):237-242.

5. Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol 2008;1(1):11-22.

6. Cooper AL, Vermillion ST, Soper DE. Qualitative human chorionic gonadotropin testing of cervicovaginal washings for the detection of preterm premature rupture of membranes. Am J Obst Gyn 2004;191:593-597.

7. Esra E, Cem T, Orhan U, Ramazan D, Birol C. Diagnosis of premature rupture of membranes by identification of β-HCG in vaginal washing fluid. Euro J of Obst & Gin and Rep Biol 2003;107:37-40.

8. Carranza Lira S, Negrete López M, Quinzaños Fresnedo C, Leaños Miranda A. Utilidad de la detección cualitativa de hCG en el lavado cervicovaginal para el diagnóstico de rotura prematura de membranas. Ginecol Obstet Mex 2009;77(3):142-146.

9. Bufalino FG, Aponte Cubillán A, Carrillo García H, Freddy B, y col. β-hCG en fluidos vaginales como marcador de rotura prematura de membrana. Rev Obstet Ginecol Venez 2003;63(4).

10. Ibarra Estrada E, Herrera Villalobos JE, Ávila Esquivel F. Nueva alternativa diagnóstica en pacientes con rotura prematura de membranas. Archivos Investigación Materno Infantil 2009;1(3):123-126.